ECAB will hold its first ever thematic meeting on HIV\, TB a
nd HCV diagnostics on 17-19 June 2016 . Several large companies have confi
rmed attendance. The meeting report and the minutes will be available afte
r the meeting\, and reports will also be availabel on Facebook and Twitter
.

HIVR4P is the only global conference that supports cross-fer
tilization among research on HIV vaccines\, microbicides\, PrEP\, treatmen
t as prevention\, and other biomedical prevention approaches\, while also
providing a venue to discuss the research findings\, questions\, and prior
ities specific to each.

The EATG is traditionally one of the key community partners
at the Glasgow Conference. This event also concludes the third round of th
e STEP-UP Training Academy advocacy training for young activi
sts.

AASLD is working hard to prepare and make 2016 a banner year
– there are lots of exciting changes designed to enhance your experience
and offer you more flexibility than ever before. This must-attend event ga
thers hepatologists from around the world to exchange the latest research\
, discuss new developments in treatment outcomes\, and network with other
experts in the field. Large community representation is expected.

\n

See more at: http://www.aasld.org/events-professional-development/liver-me
eting#sthash.J6hl8rFx.dpuf

The 2016 ETW will be the 4th of its kind. The three previous
testing weeks have shown great initiatives in all kinds of different form
s and shapes from all over Europe – all working towards increasing awarene
ss of the benefits of testing.

\n

Testing is important all ye
ar around!

\n

The ETW aims at increasing awareness regardi
ng the benefits of HIV and hepatitis testing\, so that more people become
knowledgeable about their risks\, understand that there is effective treat
ment available and are aware of their HIV and/ or hepatitis status. The ET
W unites Europe for this one week with this common aim\, BUT this
aim applies and is important all year around.

World AIDS Day is held on the 1st December each year and is
an opportunity for people worldwide to unite in the fight against HIV\, sh
ow their support for people living with HIV and to commemorate people who
have died. World AIDS Day was the first ever global health day\, held for
the first time in 1988.

The purpose is to provide information about the study and di
scuss the role of community as support for the clinical trial participants
in the countries where the EHVA trials are conducted (France\, Italy\, UK
\, Spain\, Germany and Switzerland).

A European Community Advisory Board (ECAB
) on HIV is being held in Brussels this weekend under the direction of the
newly elected ECAB Chair\, Luis Mendao.

\n

Eighteen treatment advoca
tes and one academic researcher from twelve countries will represent the c
ommunity of people living with HIV/AIDS in the WHO Europe region. They wil
l be meeting with three of the leading pharmaceutical companies in the HIV
field -Gilead Science\, ViiV Healthcare and Janssen- and provide their vi
ews on the HIV pipelines that will be presented.

\n

\n

The age
nda of the meeting will cover the following topics:

\n

\n

\n<
li>new ARVs and therapeutic options for HIV treatment\n

options fo
r paediatric treatments and safety issues

\n

innovative PrEP strat
egies

\n

plans for vaccine and cure programmes

\n

integratio
n of patient reported outcomes in clinical research

\n

\n

\n

A strategic session on Sunday will focus on plans for ECAB activities
in 2019.

The meeting serves as a platform for discussion between the
community and industry on updates in the drugs/cure pipeline\, clinical tr
ials and issues pertaining to viral hepatitis treatment (with a focus on h
epatitis B & C). It is also intended to promote discussion within the comm
unity on strategic goals and planning next steps for treatment advocacy in
viral hepatitis.

The meeting serves as a platform for discussion between the
community and industry on updates in the drugs/cure pipeline\, clinical tr
ials and issues pertaining to viral hepatitis treatment (with a focus on h
epatitis B & C). It is also intended to promote discussion within the comm
unity on strategic goals and planning next steps for treatment advocacy in
viral hepatitis.

The HIV/AIDS Civil Society Forum (CSF) is an informal adviso
ry body established in 2005 by the European Commission to facilitate the p
articipation of NGOs and networks\, including those representing People Li
ving with HIV/AIDS\, in European policy development and implementation as
well as to exchange information. The CSF is linked with the work of the HI
V/AIDS Think Tank and provides advise on issues discussed by the Think Tan
k. Meetings of CSF are co-organised by the Commission and the two networks
representing the civil society in the Think Tank. Members of the CSF come
from all over Europe and are selected by the Commission following a call
for expression of interest. Jointly managed by the EATG and AIDS Action Europe.

The European AIDS Treatment Group and HIV in Europe are co-host
ing a multi-stakeholder breakfast workshop to discuss solutions to overcom
e practical challenges in implementing testing guidelines\, the optimal us
e of new diagnostic technologies and evolution of diagnosis algorithms.